CASP3 and neoplasm: Since the patient and tissue characteristics in this group was markedly different from the first cohort, with a majority of tissues being primary tumours and median caspase-3 IRS being lower than in the pretreated cohort, with an IRS of 1.8 in primary tumours and 2.0 in metastases, respectively.